Estradiol-containing drug delivery system

Details for Australian Patent Application No. 2009214193 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Zurth, Christian; Funke, Adrian; General, Sascha; Schafers, Matthias; Terebesi, Ildiko; Diefenbach, Konstanze; Holler, Thomas; Alincic-Kunz, Sofia

Agent Davies Collison Cave

Pub. Number AU-A-2009214193

PCT Pub. Number WO2009/101021

Priority 61/028,302 13.02.08 US; 08002633.9 13.02.08 EP

Filing date 5 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/101021 Priority application(s): WO2009/101021

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214194-Heterocyclic antiviral compounds

2009214190-3-alkyl-piperazine derivatives and uses thereof